Asia-Pacific Multiplex Assay Market 2024-2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	127 Pages	Triton Market Research	March, 2024	TRTN18685706

Best Price Guarantee
Price	from $1,500
Length	127 Pages
Publisher	Triton Market Research
Published Date	March, 2024
SKU	TRTN18685706

Asia-Pacific Multiplex Assay Market 2024-2032

Market Outlook

As per Triton Market Research, the Asia-Pacific multiplex assay market is set to progress at a CAGR of 9.34% during 2024-2032. ASEAN countries, Australia & New Zealand, Japan, India, China, South Korea, and the Rest of Asia-Pacific are examined in the regional market.

Enhancements in India's healthcare infrastructure, coupled with ongoing reforms and increased expenditures, are poised to drive market growth. The significant population surge and advancements in healthcare infrastructure serve as pivotal factors propelling this expansion. Projections suggest India's population will surpass 1.7 billion by 2050, overtaking China. As India's elderly demographic expands, a corresponding rise in healthcare demand is anticipated.

In South Korea, the multiplex assay market has seen steady growth, fueled by a growing need for high-quality healthcare. This demand surge is particularly noticeable in molecular testing and point-of-care testing (POCT). Government efforts, such as endorsing medical tourism, implementing u-healthcare, and regulating multiplex assays, further bolster this trend.

Competitive Outlook

The key companies in the multiplex assay market comprise Abcam Limited, Bio-Rad Laboratories, F Hoffmann-La Roche Ltd, and Agilent Technologies Inc.

1. Asia-pacific Multiplex Assay Market- Summary
2. Industry Outlook: 2.1. Impact Analysis On The Multiplex Assay Market; 2.1.1. Impact Of Covid-19 On The Multiplex Assay Market; 2.2. Porter’s Five Forces Model; 2.2.1. Threat Of New Entrants; 2.2.2. Threat Of Substitute Products; 2.2.3. Bargaining Power Of Buyers; 2.2.4. Bargaining Power Of Suppliers; 2.2.5. Competitive Rivalry; 2.3. Key Buying Impact Analysis; 2.3.1. Analyte Coverage; 2.3.2. Speed; 2.3.3. Multiplexing Capability; 2.3.4. Ease Of Use; 2.3.5. Automation; 2.4. Market Attractiveness Index; 2.5. Key Market Strategies; 2.5.1. Contracts And Partnerships; 2.5.2. Business Expansions & Divestitures; 2.5.3. Acquisitions & Mergers; 2.5.4. Product Launches & Developments; 2.6. Market Drivers; 2.6.1. Adoption Of Personalized Medicines; 2.6.2. High Adoption Of Multiplex Assays Over Traditional Methods; 2.6.3. Increasing Prevalence Of Chronic Diseases; 2.7. Market Challenges; 2.7.1. Issues Related To Cross-reactivity And Assay Interference; 2.7.2. Challenge In Achieving Adequate Assay Range; 2.7.3. Dearth Of Skilled Professionals; 2.8. Market Opportunities; 2.8.1. Technological Advancements In Assay Platforms; 2.8.2. Rapid Growth Of Companion Diagnostics; 2.8.3. Growth In Drug Discovery Initiatives; 2.9. Analyst Perspective
3. Asia-pacific Multiplex Assay Market - By Product And Service: 3.1. Reagents And Consumables; 3.2. Instruments And Accessories; 3.3. Software And Services
4. Asia-pacific Multiplex Assay Market - By Type: 4.1. Protein-based Multiplex Assay; 4.2. Nucleic Acid-based Multiplex Assay; 4.3. Other Multiplex Assays
5. Asia-pacific Multiplex Assay Market - By Application: 5.1. Research And Development; 5.2. Clinical Diagnostics; 5.3. Companion Diagnostics
6. Asia-pacific Multiplex Assay Market - By Technology: 6.1. Multiplex Protein Microarray; 6.2. Multiplex Pcr; 6.3. Other Technologies
7. Asia-pacific Multiplex Assay Market - By Industry Vertical: 7.1. Pharmaceutical & Biotechnology Companies; 7.2. Research Institutes; 7.3. Clinical Laboratories; 7.4. Hospitals
8. Asia-pacific Multiplex Assay Market – By Country Outlook: 8.1. China; 8.1.1. China Multiplex Assays Market Forecast & Prospects; 8.2. Japan; 8.2.1. Japan Multiplex Assays Market Forecast & Prospects; 8.3. India; 8.3.1. India Multiplex Assays Market Forecast & Prospects; 8.4. Asean Countries; 8.4.1. Asean Countries Multiplex Assays Market Forecast & Prospects; 8.5. Australia & New Zealand; 8.5.1. Australia & New Zealand Multiplex Assays Market Forecast & Prospects; 8.6. South Korea; 8.6.1. South Korea Multiplex Assays Market Forecast & Prospects; 8.7. Rest Of Asia-pacific; 8.7.1. Rest Of Asia-pacific Multiplex Assays Market Forecast & Prospects
9. Competitive Landscape: 9.1. Abcam Limited; 9.1.1. Overview; 9.1.2. Product Portfolio; 9.2. Agilent Technologies Inc; 9.2.1. Overview; 9.2.2. Product Portfolio; 9.2.3. Key Strengths; 9.2.4. Key Challenges; 9.3. Becton Dickinson And Company (Bd); 9.3.1. Overview; 9.3.2. Product Portfolio; 9.3.3. Key Strengths; 9.3.4. Key Challenges; 9.4. Bio-rad Laboratories Inc; 9.4.1. Overview; 9.4.2. Product Portfolio; 9.4.3. Key Strengths; 9.4.4. Key Challenges; 9.5. Bio-techne Corporation; 9.5.1. Overview; 9.5.2. Product Portfolio; 9.6. F. Hoffmann-la Roche Ltd; 9.6.1. Overview; 9.6.2. Product Portfolio; 9.6.3. Key Strengths; 9.6.4. Key Challenges; 9.7. Illumina Inc; 9.7.1. Overview; 9.7.2. Product Portfolio; 9.7.3. Key Strengths; 9.7.4. Key Challenges; 9.8. Merck Millipore; 9.8.1. Overview; 9.8.2. Product Portfolio; 9.9. Olink Proteomics Ab; 9.9.1. Overview; 9.9.2. Product Portfolio; 9.10. Qiagen Nv; 9.10.1. Overview; 9.10.2. Product Portfolio; 9.10.3. Key Strengths; 9.10.4. Key Challenges; 9.11. Randox Laboratories Ltd; 9.11.1. Overview; 9.11.2. Product Portfolio; 9.12. Seegene Inc; 9.12.1. Overview; 9.12.2. Product Portfolio; 9.13. Siemens Healthineers Ag; 9.13.1. Overview; 9.13.2. Product Portfolio; 9.13.3. Key Strengths; 9.13.4. Key Challenges; 9.14. Thermo Fisher Scientific Inc; 9.14.1. Overview; 9.14.2. Product Portfolio; 9.14.3. Key Strengths; 9.14.4. Key Challenges
10. Research Methodology & Scope: 10.1. Research Scope & Deliverables; 10.2. Sources Of Data; 10.3. Research Methodology
List Of Tables: Table 1: Asia-pacific Multiplex Assay Market, By Country Outlook, Historical Years, 2020-2023 (In $ Million); Table 2: Asia-pacific Multiplex Assay Market, By Country Outlook, Forecast Years, 2024-2032 (In $ Million); Table 3: Contracts And Partnerships; Table 4: List Of Business Expansions & Divestitures; Table 5: Acquisitions & Mergers; Table 6: List Of New Product Launches & Developments; Table 7: Asia-pacific Multiplex Assay Market, By Product And Service, 2024-2032 (In $ Million); Table 8: Asia-pacific Multiplex Assay Market, By Type, 2024-2032 (In $ Million); Table 9: Asia-pacific Multiplex Assay Market, By Application, 2024-2032 (In $ Million); Table 10: Asia-pacific Multiplex Assay Market, By Technology, 2024-2032 (In $ Million); Table 11: Asia-pacific Multiplex Assay Market, By Industry Vertical, 2024-2032 (In $ Million); Table 12: Asia-pacific Multiplex Assay Market, By Country Outlook, 2024-2032 (In $ Million)
List Of Figures: Figure 1: Asia-pacific Multiplex Assay Market, By Product And Service, 2023 & 2032, (In %); Figure 2: Asia-pacific Multiplex Assay Market, By Reagents And Consumables, 2024-2032 (In $ Million); Figure 3: Asia-pacific Multiplex Assay Market, By Instruments And Accessories, 2024-2032 (In $ Million); Figure 4: Asia-pacific Multiplex Assay Market, By Software And Services, 2024-2032 (In $ Million); Figure 5: Asia-pacific Multiplex Assay Market, By Type, 2023 & 2032 (In %); Figure 6: Asia-pacific Multiplex Assay Market, By Protein-based Multiplex Assay, 2024-2032 (In $ Million); Figure 7: Asia-pacific Multiplex Assay Market, By Nucleic Acid-based Multiplex Assay, 2024-2032 (In $ Million); Figure 8: Asia-pacific Multiplex Assay Market, By Other Multiplex Assays, 2024-2032 (In $ Million); Figure 9: Asia-pacific Multiplex Assay Market, By Application, 2023 & 2032 (In %); Figure 10: Asia-pacific Multiplex Assay Market, By Research And Development, 2024-2032 (In $ Million); Figure 11: Asia-pacific Multiplex Assay Market, By Clinical Diagnostics, 2024-2032 (In $ Million); Figure 12: Asia-pacific Multiplex Assay Market, By Companion Diagnostics, 2024-2032 (In $ Million); Figure 13: Asia-pacific Multiplex Assay Market, By Technology, 2023 & 2032 (In %); Figure 14: Asia-pacific Multiplex Assay Market, By Multiplex Protein Microarray, 2024-2032 (In $ Million); Figure 15: Asia-pacific Multiplex Assay Market, By Multiplex Pcr, 2024-2032 (In $ Million); Figure 16: Asia-pacific Multiplex Assay Market, By Other Technologies, 2024-2032 (In $ Million); Figure 17: Asia-pacific Multiplex Assay Market, By Industry Vertical, 2023 & 2032 (In %); Figure 18: Asia-pacific Multiplex Assay Market, By Pharmaceutical & Biotechnology Companies, 2024-2032 (In $ Million); Figure 19: Asia-pacific Multiplex Assay Market, By Research Institutes, 2024-2032 (In $ Million); Figure 20: Asia-pacific Multiplex Assay Market, By Clinical Laboratories, 2024-2032 (In $ Million); Figure 21: Asia-pacific Multiplex Assay Market, By Hospitals, 2024-2032 (In $ Million); Figure 22: Asia-pacific Multiplex Assay Market, By Country Outlook, 2023 & 2032 (In %); Figure 23: China Multiplex Assay Market 2024-2032 (In $ Million); Figure 24: Japan Multiplex Assay Market 2024-2032 (In $ Million); Figure 25: India Multiplex Assay Market 2024-2032 (In $ Million); Figure 26: Asean Countries Multiplex Assay Market 2024-2032 (In $ Million); Figure 27: Australia & New Zealand Multiplex Assay Market 2024-2032 (In $ Million); Figure 28: South Korea Multiplex Assay Market 2024-2032 (In $ Million); Figure 29: Rest Of Asia-pacific Multiplex Assay Market 2024-2032 (In $ Million)